The first batch of Biocad company’s drug “Seniprutug” for the treatment of ankylosing spondylitis was made available to the public. This was reported by the press service of the Ministry of Health of Russia. telegram channel departments.
It was reported that the drug was developed by scientists from the eponymous Russian National Research Medical University. NI Pirogov Ministry of Health of Russia, Institute of Bioorganic Chemistry Academicians MM Shemyakin and Yu.A. Ovchinnikov RAS and the Russian company Biocad.
According to Sergei Lukyanov, rector of Pirogov University, “Seniprutug” helps to completely stop ankylosing spondylitis, does not suppress the immune system and is not addictive. It is noted that previous analogues of the drug were less effective.
Ankylosing spondylitis is a chronic, non-infectious lesion of the spinal joints and periarticular tissues. The causes of ankylosing spondylitis are not fully determined.
Previously Russian company produced Medicine used to treat ankylosing spondylitis.
Previously gynecologist and pharmacist explainedHow does the HPV vaccine protect against cancer?